Statera Biopharma, Inc. Increase (Decrease) in Accounts Payable
Statera Biopharma, Inc. reported Increase (Decrease) in Accounts Payable of -$325.83 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2019-03-07
- Statera Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2015-03-31 was -$57.91K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2014-12-31 was $326.84K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2014-09-30 was $179.75K, a 1416.37% increase year-over-year.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for the quarter ending 2014-06-30 was $225.84K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2018 was -$325.83K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2017 was -$1.01M, a 914.71% decline from fiscal 2016.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2016 was $124.01K.
- Statera Biopharma, Inc. increase (decrease) in accounts payable for fiscal 2015 was -$833.95K, a 281.55% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$325.83K 10-K · filed 2019-03-07 | ||||
| 2017-12-31 | -$1.01M 10-K · filed 2019-03-07 | -$138.58K 10-K · filed 2018-03-06 | |||
| 2016-12-31 | $124.01K 10-K · filed 2018-03-06 | ||||
| 2015-12-31 | -$833.95K 10-K · filed 2017-02-22 | ||||
| 2015-03-31 | -$57.91K 10-Q · filed 2015-05-07 | $268.93K derived: sum of 2 quarters · filed 2016-02-23 | $448.68K derived: sum of 3 quarters · filed 2016-02-23 | $674.51K derived: sum of 4 quarters · filed 2016-02-23 | |
| 2014-12-31 | $326.84K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $506.59K derived: sum of 2 quarters · filed 2016-02-23 | $732.42K derived: sum of 3 quarters · filed 2016-02-23 | $459.34K 10-K · filed 2016-02-23 | |
| 2014-09-30 | $179.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $405.58K derived: sum of 2 quarters · filed 2014-11-10 | $132.50K 10-Q · filed 2014-11-10 | -$270.85K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2014-06-30 | $225.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$47.25K 10-Q · filed 2014-08-11 | -$450.60K derived: sum of 3 quarters · filed 2015-05-07 | -$438.75K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2014-03-31 | -$273.09K 10-Q · filed 2015-05-07 | -$676.44K derived: sum of 2 quarters · filed 2015-05-07 | -$664.58K derived: sum of 3 quarters · filed 2015-05-07 | -$700.21K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | -$403.35K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$391.50K derived: sum of 2 quarters · filed 2015-02-27 | -$427.13K derived: sum of 3 quarters · filed 2015-02-27 | -$713.50K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $11.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$23.77K derived: sum of 2 quarters · filed 2014-11-10 | -$310.15K 10-Q · filed 2014-11-10 | $771.01K derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | -$35.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$322.00K 10-Q · filed 2014-08-11 | $759.15K derived: sum of 3 quarters · filed 2015-02-27 | $521.83K derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$286.38K 10-Q · filed 2014-05-12 | $794.78K derived: sum of 2 quarters · filed 2015-02-27 | $557.46K derived: sum of 3 quarters · filed 2015-02-27 | $169.61K derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $843.84K derived: sum of 2 quarters · filed 2015-02-27 | $455.99K derived: sum of 3 quarters · filed 2015-02-27 | $609.52K 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$237.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$625.17K derived: sum of 2 quarters · filed 2013-11-08 | -$471.63K 10-Q · filed 2013-11-08 | -$885.67K derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-06-30 | -$387.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$234.31K 10-Q · filed 2013-08-09 | -$648.35K derived: sum of 3 quarters · filed 2014-03-17 | $32.25K derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-03-31 | $153.53K 10-Q · filed 2013-05-09 | -$260.50K derived: sum of 2 quarters · filed 2014-03-17 | $420.10K derived: sum of 3 quarters · filed 2014-03-17 | -$205.95K derived: sum of 4 quarters · filed 2014-03-17 | |
| 2011-12-31 | -$414.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $266.56K derived: sum of 2 quarters · filed 2014-03-17 | -$359.48K derived: sum of 3 quarters · filed 2014-03-17 | -$348.28K 10-K · filed 2014-03-17 | |
| 2011-09-30 | $680.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $54.55K derived: sum of 2 quarters · filed 2012-11-09 | $65.75K 10-Q · filed 2012-11-09 | $1.00M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | -$626.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$614.85K 10-Q · filed 2012-08-09 | $321.49K derived: sum of 3 quarters · filed 2013-03-18 | -$428.44K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $11.20K 10-Q · filed 2012-05-07 | $947.53K derived: sum of 2 quarters · filed 2013-03-18 | $197.61K derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $936.33K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $186.41K derived: sum of 2 quarters · filed 2013-03-18 | $53.37K 10-K · filed 2013-03-18 | ||
| 2010-09-30 | -$749.92K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-14 | -$882.96K 10-Q/A · filed 2011-11-14 | |||
| 2010-06-30 | -$133.04K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | $106.67K 10-K · filed 2012-03-13 |